The fruRBA operon is necessary for group A streptococcal growth in fructose and for resistance to neutrophil killing during growth in whole human blood

Infection and Immunity

Volumn 84, Issue 4, 2016, Pages 1016-1031

  Valdes, Kayla M ^a   Sundar, Ganesh S ^a   Vega, Luis A ^a   Belew, Ashton T ^a   Islam, Emrul ^a   Binet, Rachel ^b   El Sayed, Najib M ^a   Le Breton, Yoann ^a   McIver, Kevin S ^a  

^a Bldg 142   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHOSPHOFRUCTOKINASE; ALPHA LACTOSE; BACTERIAL PROTEIN; CELLOBIOSE; FRUCTOSE; FRURBA PROTEIN; GALACTOSE; GLUCOSE; MALTOSE; MALTOTRIOSE; MANNITOL; MANNOSE; METHYLGLUCOSIDE; N ACETYLGALACTOSAMINE; SALICIN; SUCROSE; TREHALOSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CARBON METABOLISM; CARBON SOURCE; CARBON UTILIZATION; CATABOLITE REPRESSION; CELL KILLING; CONTROLLED STUDY; EXTRACELLULAR TRAP; FEMALE; GENE EXPRESSION; GENE LOCUS; GROUP A STREPTOCOCCAL INFECTION; HEXOSE TRANSPORT; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL; NONHUMAN; OPEN READING FRAME; OPERON; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; START CODON; STREPTOCOCCUS PYOGENES; TRANSCRIPTION INITIATION SITE; ANIMAL; BACTERIAL CHROMOSOME; BLOOD; CHROMOSOMAL MAPPING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; MUTATION; PHYSIOLOGY; SERUM BACTERICIDAL ACTIVITY; STREPTOCOCCUS INFECTION;

ANIMALS; BACTERIAL PROTEINS; BLOOD; BLOOD BACTERICIDAL ACTIVITY; CHROMOSOME MAPPING; CHROMOSOMES, BACTERIAL; FEMALE; FRUCTOSE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICE; MUTATION; NEUTROPHILS; OPERON; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84962787083     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01296-15     Document Type: Article

References (68)

1. Gorke B, Stulke J. 2008. Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nat Rev Microbiol 6:613-624. http://dx.doi.org/10.1038/nrmicro1932.
2. Deutscher J, Francke C, Postma PW. 2006. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol Mol Biol Rev 70:939-1031. http://dx.doi.org/10.1128/MMBR.00024-06.
3. Deutscher J, Herro R, Bourand A, Mijakovic I, Poncet S. 2005. P-Ser-HPr-a link between carbon metabolism and the virulence of some patho-genic bacteria. Biochim Biophys Acta 1754:118-125. http://dx.doi.org/10.1016/j.bbapap.2005.07.029.
4. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685-694. http://dx.doi.org/10.1016/S1473-3099(05)70267-X.
5. Bisno AL, Brito MO, Collins CM. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3:191-200. http://dx.doi.org/10.1016/S1473-3099(03)00576-0.
6. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470-511. http://dx.doi.org/10.1128/CMR.13.3.470-511.2000.
7. Hondorp ER, Hou SC, Hause LL, Gera K, Lee CE, McIver KS. 2013. PTS phosphorylation of Mga modulates regulon expression and virulence in the group A streptococcus. Mol Microbiol 88:1176-1193. http://dx.doi.org/10.1111/mmi.12250.
8. Loughman JA, Caparon MG. 2006. A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. EMBO J 25:5414-5422. http://dx.doi.org/10.1038/sj.emboj.7601393.
9. Kinkel TL, McIver KS. 2008. CcpA-mediated repression of streptolysin S expression and virulence in the group A streptococcus. Infect Immun 76:3451-3463. http://dx.doi.org/10.1128/IAI.00343-08.
10. Shelburne SA, III, Keith D, Horstmann N, Sumby P, Davenport MT, Graviss EA, Brennan RG, Musser JM. 2008. A direct link between carbohydrate utilization and virulence in the major human pathogen groupA Streptococcus. Proc Natl Acad SciUSA105:1698-1703. http://dx.doi.org/10.1073/pnas.0711767105.
11. Kietzman CC, Caparon MG. 2010. CcpA and LacD.1 affect temporal regulation of Streptococcus pyogenes virulence genes. Infect Immun 78: 241-252. http://dx.doi.org/10.1128/IAI.00746-09.
12. Gera K, Le T, Jamin R, Eichenbaum Z, McIver KS. 2014. The phosphoenolpyruvate phosphotransferase system in group A streptococcus acts to reduce streptolysin S activity and lesion severity during soft tissue infection. Infect Immun 82:1192-1204. http://dx.doi.org/10.1128/IAI.01271-13.
13. Loo CY, Mitrakul K, Voss IB, Hughes CV, Ganeshkumar N. 2003. Involvement of an inducible fructose phosphotransferase operon in Streptococcus gordonii biofilm formation. J Bacteriol 185:6241-6254. http://dx.doi.org/10.1128/JB.185.21.6241-6254.2003.
14. Pridgeon JW, Li Y, Yildirim-Aksoy M, Song L, Klesius PH, Srivastava KK, Reddy PG. 2013. Fitness cost, gyrB mutation, and absence of phosphotransferase system fructose specific IIABC component in novobiocinresistant Streptococcus iniae vaccine strain ISNO. Vet Microbiol 165:384-391. http://dx.doi.org/10.1016/j.vetmic.2013.04.001.
15. Le Breton Y, Mistry P, Valdes KM, Quigley J, Kumar N, Tettelin H, McIver KS. 2013. Genome-wide identification of genes required for fitness of group A streptococcus in human blood. Infect Immun 81:862-875. http://dx.doi.org/10.1128/IAI.00837-12.
16. Sachla AJ, Le Breton Y, Akhter F, McIver KS, Eichenbaum Z. 2014. The crimson conundrum: heme toxicity and tolerance in GAS. Front Cell Infect Microbiol 4:159.
17. Shelburne SA, III, Keith DB, Davenport MT, Horstmann N, Brennan RG, Musser JM. 2008. Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol Microbiol 69:436-452. http://dx.doi.org/10.1111/j.1365-2958.2008.06290.x.
18. Barriere C, Veiga-da-Cunha M, Pons N, Guedon E, van Hijum SA, Kok J, Kuipers OP, Ehrlich DS, Renault P. 2005. Fructose utilization in Lactococcus lactis as a model for low-GC gram-positive bacteria: its regulator, signal, and DNA-binding site. J Bacteriol 187:3752-3761. http://dx.doi.org/10.1128/JB.187.11.3752-3761.2005.
19. Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 68:3523-3534. http://dx.doi.org/10.1128/IAI.68.6.3523-3534.2000.
20. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM. 2005. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A streptococcus involved multiple horizontal gene transfer events. J Infect Dis 192:771-782. http://dx.doi.org/10.1086/432514.
21. Le Breton Y, McIver KS. 2013. Genetic manipulation of Streptococcus pyogenes (the group A streptococcus, GAS). Curr Prot Microbiol 9D:3.1.
22. Hanahan D, Meselson M. 1983. Plasmid screening at high colony density. Methods Enzymol 100:333-342. http://dx.doi.org/10.1016/0076-6879(83)00066-X.
23. Rose RE. 1988. The nucleotide sequence of pACYC184. Nucleic Acids Res 16:355. http://dx.doi.org/10.1093/nar/16.1.355.
24. Ribardo DA, Lambert TJ, McIver KS. 2004. Role of Streptococcus pyogenes two-component response regulators in the temporal control of Mga and the Mga-regulated virulence gene emm. Infect Immun 72:3668-3673. http://dx.doi.org/10.1128/IAI.72.6.3668-3673.2004.
25. Leday TV, Gold KM, Kinkel TL, Roberts SA, Scott JR, McIver KS. 2008. TrxR, a new CovR-repressed response regulator that activates the Mga virulence regulon in group A Streptococcus. Infect Immun 76:4659-4668. http://dx.doi.org/10.1128/IAI.00597-08.
26. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114-2120. http://dx.doi.org/10.1093/bioinformatics/btu170.
27. Langmead B. 2010. Aligning short sequencing reads with Bowtie. Curr Prot Bioinformatics Chapter 11:Unit 11.7. http://dx.doi.org/10.1002/0471250953.bi1107s32.
28. Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie. 2 Nat Methods 9:357-359. http://dx.doi.org/10.1038/nmeth.1923.
29. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7:562-578. http://dx.doi.org/10.1038/nprot.2012.016.
30. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The sequence alignment/map format and SAMtools. Bioinformatics 25:2078-2079. http://dx.doi.org/10.1093/bioinformatics/btp352.
31. Anders S, Pyl PT, Huber W. 2015. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31:166-169. http://dx.doi.org/10.1093/bioinformatics/btu638.
32. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nat Biotechnol 29:24-26. http://dx.doi.org/10.1038/nbt.1754.
33. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. 2015. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. http://dx.doi.org/10.1093/nar/gkv007.
34. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. 2009. Circos: an information aesthetic for comparative genomics. Genom Res 19:1639-1645. http://dx.doi.org/10.1101/gr.092759.109.
35. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. 1999. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27: 29-34. http://dx.doi.org/10.1093/nar/27.1.29.
36. Young MD, Wakefield MJ, Smyth GK, Oshlack A. 2010. Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11:R14. http://dx.doi.org/10.1186/gb-2010-11-2-r14.
37. Yu G, Wang LG, Han Y, He QY. 2012. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284-287. http://dx.doi.org/10.1089/omi.2011.0118.
38. Beissbarth T, Speed TP. 2004. GOstat: find statistically overrepresented gene ontologies within a group of genes. Bioinformatics 20:1464-1465. http://dx.doi.org/10.1093/bioinformatics/bth088.
39. Alexa A, Rahnenfuhrer J, Lengauer T. 2006. Improved scoring of functional groups from gene expression data by decorrelatingGOgraph structure. Bioinformatics 22:1600-1607. http://dx.doi.org/10.1093/bioinformatics/btl140.
40. Sung K, Khan SA, Nawaz MS, Khan AA. 2003. A simple and efficient Triton X-100 boiling and chloroform extraction method of RNA isolation from Gram-positive and Gram-negative bacteria. FEMS Microbiol Lett 229:97-101. http://dx.doi.org/10.1016/S0378-1097(03)00791-2.
41. Lancefield RC. 1957. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med 106:525-544. http://dx.doi.org/10.1084/jem.106.4.525.
42. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
43. LaSarre B, Federle MJ. 2011. Regulation and consequence of serine catabolism in Streptococcus pyogenes. J Bacteriol 193:2002-2012. http://dx.doi.org/10.1128/JB.01516-10.
44. Savic DJ, McShan WM, Ferretti JJ. 2002. Autonomous expression of the slo gene of the bicistronic nga-slo operon of Streptococcus pyogenes. Infect Immun 70:2730-2733. http://dx.doi.org/10.1128/IAI.70.5.2730-2733.2002.
45. Wen ZT, Browngardt C, Burne RA. 2001. Characterization of two operons that encode components of fructose-specific enzyme II of the sugar: phosphotransferase system of Streptococcus mutans. FEMS Microbiol Lett 205:337-342. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10969.x.
46. Kolaczkowska E, Kubes P. 2013. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159-175. http://dx.doi.org/10.1038/nri3399.
47. Ajdic D, Pham VT. 2007. Global transcriptional analysis of Streptococcus mutans sugar transporters using microarrays. J Bacteriol 189:5049-5059. http://dx.doi.org/10.1128/JB.00338-07.
48. Barrangou R, Azcarate-Peril MA, Duong T, Conners SB, Kelly RM, Klaenhammer TR. 2006. Global analysis of carbohydrate utilization by Lactobacillus acidophilus usingcDNAmicroarrays. Proc Natl Acad SciUSA103:3816-3821. http://dx.doi.org/10.1073/pnas.0511287103.
49. Kornberg HL. 2001. Routes for fructose utilization by Escherichia coli. J Mol Microbiol Biotechnol 3:355-359.
50. Kelley LA, Sternberg MJ. 2009. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4:363-371. http://dx.doi.org/10.1038/nprot.2009.2.
51. Van den Bogert B, Boekhorst J, Herrmann R, Smid EJ, Zoetendal EG, Kleerebezem M. 2013. Comparative genomics analysis of Streptococcus isolates from the human small intestine reveals their adaptation to a highly dynamic ecosystem. PLoS One 8:e83418. http://dx.doi.org/10.1371/journal.pone.0083418.
52. Kreft J, Vazquez-Boland JA. 2001. Regulation of virulence genes in Listeria. Int J Med Microbiol 291:145-157. http://dx.doi.org/10.1078/1438-4221-00111.
53. Ferenci T, Kornberg HL. 1971. Role of fructose-1, 6-diphosphatase in fructose utilization by Escherichia coli. FEBS Lett 14:360-363. http://dx.doi.org/10.1016/0014-5793(71)80301-0.
54. Voigt C, Bahl H, Fischer RJ. 2014. Identification of PTS(Fru) as the major fructose uptake system of Clostridium acetobutylicum. Appl Microbiol Biotechnol 98:7161-7172. http://dx.doi.org/10.1007/s00253-014-5809-1.
55. Chavarria M, Durante-Rodriguez G, Krell T, Santiago C, Brezovsky J, Damborsky J, de Lorenzo V. 2014. Fructose 1-phosphate is the one and only physiological effector of the Cra (FruR) regulator of Pseudomonas putida. FEBS Open Biol 4:377-386. http://dx.doi.org/10.1016/j.fob.2014.03.013.
56. Chavarria M, Santiago C, Platero R, Krell T, Casasnovas JM, de Lorenzo V. 2011. Fructose 1-phosphate is the preferred effector of the metabolic regulator Cra of Pseudomonas putida. J Biol Chem 286:9351-9359. http://dx.doi.org/10.1074/jbc.M110.187583.
57. Loughman JA, Caparon MG. 2007. Comparative functional analysis of the lac operons in Streptococcus pyogenes. Mol Microbiol 64:269-280. http://dx.doi.org/10.1111/j.1365-2958.2007.05663.x.
58. Kim HK, Missiakas D, Schneewind O. 2014. Mouse models for infectious diseases caused by Staphylococcus aureus. J Immunol Methods 410:88-99. http://dx.doi.org/10.1016/j.jim.2014.04.007.
59. Mestas J, Hughes CC. 2004. Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731-2738. http://dx.doi.org/10.4049/jimmunol.172.5.2731.
60. Medina E, Lengeling A. 2005. Genetic regulation of host responses to group A streptococcus in mice. Brief Funct Genomics Proteomics 4:248-257. http://dx.doi.org/10.1093/bfgp/4.3.248.
61. Scaramuzzino DA, McNiff JM, Bessen DE. 2000. Humanized in vivo model for streptococcal impetigo. Infect Immun 68:2880-2887. http://dx.doi.org/10.1128/IAI.68.5.2880-2887.2000.
62. Gladysheva IP, Turner RB, Sazonova IY, Liu L, Reed GL. 2003. Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci U S A 100:9168-9172. http://dx.doi.org/10.1073/pnas.1631716100.
63. Khil J, Im M, Heath A, Ringdahl U, Mundada L, Cary Engleberg N, Fay WP. 2003. Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms. J Infect Dis 188:497-505. http://dx.doi.org/10.1086/377100.
64. Accardo P, Sanchez-Corral P, Criado O, Garcia E, Rodriguez de Cordoba S. 1996. Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site. J Immunol 157:4935-4939.
65. McArthur JD, Walker MJ. 2006. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development. Mol Microbiol 59:1-4. http://dx.doi.org/10.1111/j.1365-2958.2005.04967.x.
66. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, Rozek LS, Wang X, Sjobring U, Ginsburg D. 2004. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305:1283-1286. http://dx.doi.org/10.1126/science.1101245.
67. Ermert D, Shaughnessy J, Joeris T, Kaplan J, Pang CJ, Kurt-Jones EA, Rice PA, Ram S, Blom AM. 2015. Virulence of group A streptococci is enhanced by human complement inhibitors. PLoS Pathog 11:e1005043. http://dx.doi.org/10.1371/journal.ppat.1005043.
68. Proft T, Moffatt SL, Berkahn CJ, Fraser JD. 1999. Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 189:89-102. http://dx.doi.org/10.1084/jem.189.1.89.